Western blot (WB) analysis revealed that MARK4 (p < 0.001), MAP1A (p < 0.01), and DYNLL1 (p < 0.01) protein levels were significantly lower in the T1D group, as compared to the controls (Figure 1A). The gene discussed is MAP1A; the disease is type 1 diabetes mellitus.